-
JPM26: Astellas CEO resists 'rescue BD' as $6B Xtandi patent cliff nears
15 Jan 2026 21:38 GMT
Xtandi, Astellas Pharma’s roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in 2027. As the company continues looking for external innovation to secure sustainable growth, CEO Naoki Okamura does not want …
-
Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045
14 Jan 2026 14:00 GMT
GLEN ALLEN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related …
-
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
13 Jan 2026 14:51 GMT
… new U.S. patents that further expand and … platform. The newly granted patents cover mitochondrial augmentation therapy for … core platform technology. Corresponding patents have also been granted … Syndrome and other severe genetic mitochondrial disorders. U.S …
-
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
13 Jan 2026 15:15 GMT
… new U.S. patents that further expand and … platform. The newly granted patents cover mitochondrial augmentation therapy for … core platform technology. Corresponding patents have also been granted … Syndrome and other severe genetic mitochondrial disorders. U.S …
-
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases
12 Jan 2026 14:15 GMT
… ) therapies for ultra-rare genetic diseases. Under the proposed … for patients with rare genetic diseases, often under patient … claims alleging infringement of patents and proprietary rights or … invalidate PacBio's patents or proprietary rights, among …
-
From cornfields to COVID-19 shots: Monsanto’s patent war enters the vaccine arena
12 Jan 2026 14:06 GMT
… unlawfully used foundational genetic stabilization technology Monsanto … Johnson unlawfully used foundational genetic technology pioneered by … the lawsuits, the patents covering these stabilization techniques … relied on a patented genetic "sequence and …
-
IEDA board approves assistance for 6 AI, med tech and ag tech startups
16 Jan 2026 22:03 GMT
… enables the precise delivery of genetic material into plant cells. The … care settings. The gown’s patented design meets Food and Drug … energy and advanced technologies. Its patented, acid-free process recovers high …
-
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman
16 Jan 2026 17:36 GMT
SAN FRANCISCO, Jan. 16, 2026 (GLOBE NEWSWIRE) -- On November 5, 2025, investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) saw the price of their shares tumble $18.78 (-28%) after the company reported disappointing information about VYKAT™ XR, a once- …
-
Genethon licenses core AB-1009 technology to AskBio after IND clearance
16 Jan 2026 16:38 GMT
… AskBio to address the underlying genetic cause of Pompe disease, … 2017 research article and subsequently patented by the French research institute … AB-1009, protected by patents held by Genethon and other … if the program relied on patents held by Genethon and …
-
New markers improve detection of aggressive breast cancer cells in the blood
16 Jan 2026 16:13 GMT
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC also is more likely to metastasize, or travel through the blood stream to spread to other organs, which causes most of breast …
About
© 1995-2026